HomeProductsBioactive CompoundsImmunology & InflammationCXCRNavarixin Anhydrous
Chemical structure of CAS 473727-83-2

Navarixin Anhydrous

CAS No.473727-83-2
MDL No.N/A
MFC21H23N3O5
MW397.40
InChI KeyRXIUEIPPLAFSDF-CYBMUJFWSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.473727-83-2
Product NameNavarixin Anhydrous

Biological Targets

CXCR1·CXCR2

Associated Conditions

chronic obstructive pulmonary disease·asthma·psoriasis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Pharmacological reviews • Vol. 66, Issue 1 • 2014
PMID: 24218476PMC: PMC3880466DOI: 10.1124/pr.113.007724

Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.

The Journal of pharmacology and experimental therapeutics • Vol. 322, Issue 2 • 2007
PMID: 17496166DOI: 10.1124/jpet.106.118927

Future therapeutic treatment of COPD: struggle between oxidants and cytokines.

International journal of chronic obstructive pulmonary disease • Vol. 2, Issue 3 • 2007
PMID: 18229560PMC: PMC2695202

Documentation